INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Cipla Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500087	ISIN Demat INE059A01026	Book Value 360.74	NSE Symbol CIPLA	Dividend Yield (%) 0.85	Market Cap (₹ Cr.) 123,852.12	P/E 26.61	EPS 57.63	Face Value 2

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	16,574.34	14,345.34	15,380.82	11,302.71	12,659.15
Sale of Products	15,924.20	14,690.14	15,052.48	11,060.17	12,220.22
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	2,133.20	1,271.81	328.34	290.56	438.93
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	16,574.34	14,345.34	15,380.82	11,302.71	12,659.15
Other Income	1,070.66	456.79	666.70	230.28	892.85
Total Revenue	17,645.00	14,802.13	16,047.52	11,532.99	13,552.00
Changes in Inventories	104.57	194.32	-541.93	6.41	-43.08
Cost of Material Consumed	2,617.21	2,746.50	3,616.69	2,249.35	2,999.17
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	2,360.41	1,993.39	2,850.85	1,847.85	1,363.12
Employee Benefits	2,644.21	2,335.69	2,113.78	1,703.58	1,911.08
Total Other Expenses	4,363.79	3,722.55	3,630.20	2,428.11	3,721.57
Manufacturing / Operating Expenses	1,515.13	1,246.06	1,242.13	1,140.67	1,174.99
Administrative and Selling Expenses	2,510.53	2,334.97	2,107.17	1,578.59	2,093.92
Other Expenses	338.13	141.52	280.90	-291.15	452.66
Finance Costs	20.25	22.27	26.93	45.07	36.05
Depreciation and Amortization	587.59	595.91	546.62	468.62	599.78
Total Expenses	12,698.03	11,610.63	12,243.14	8,748.99	10,587.69
Profit Before Exceptional Items and Tax	4,946.97	3,191.50	3,804.38	2,784.00	2,964.31
Exceptional Items Before Tax	0.00	-185.90	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	4,946.97	3,005.60	3,804.38	2,784.00	2,964.31
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	4,946.97	3,005.60	3,804.38	2,784.00	2,964.31
Taxation	1,232.78	861.54	921.80	739.35	646.14
Current Tax	1,226.69	901.63	949.49	756.27	545.96
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	6.09	-40.09	-27.69	-16.92	100.18
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	3,714.19	2,144.06	2,882.58	2,044.65	2,318.17
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	363.06	369.41	75.35	423.63	0.00
Profit / (Loss) from Discontinuing Operations	485.17	493.67	0.00	566.66	0.00
Tax Expenses of Discontinuing Operations	-122.11	-124.26	75.35	-143.03	0.00
Profit Attributable to Shareholders	4,077.25	2,513.47	2,957.93	2,468.28	2,318.17
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	4,077.25	2,513.47	2,957.93	2,468.28	2,318.17
Earning Per Share - Basic	50.51	31.15	36.67	30.61	28.76
Earning Per Share - Diluted	50.46	31.12	36.63	30.57	28.72
Operation Profit before Depreciation	5,554.81	3,809.68	4,377.93	3,297.69	3,600.14
Operating Profit after Depreciation	4,967.22	3,213.77	3,831.31	2,829.07	3,000.36
Dividend Per Share	13.00	8.50	5.00	5.00	4.00
Dividend Percentage	650.00	425.00	250.00	250.00	200.00
Equity Dividend	1,049.58	686.08	403.41	403.23	322.49
Weighted Average Shares - Basic	80.73	80.70	80.67	80.64	80.60
Weighted Average Shares - Diluted	80.80	80.76	80.74	80.73	80.71